Gene Therapies and Specialty Drugs: The New Frontier of Stop-Loss Risk
With single treatments exceeding $4 million, gene therapies are reshaping stop-loss underwriting. Learn about the market pressure and how carriers are responding.
Industry insights and expert analysis on stop-loss insurance and self-funding strategies.
Our team of experts is ready to help you navigate the complexities of self-funding.
Contact Our Experts